Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.

A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.

Though CAR T cells have been effective against certain blood cancers, they have not been for solid tumors. Now, a new form of highly sensitive CAR T cells aims to overcome one of the biggest barriers ...

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced a new publication validating the company’s NeXT Personal test, ...

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Nick Turner, Dr. Isaac Garcia-Murillas and their colleagues at The Institute of Cancer Research, ...

The schematic diagram of the ultra-sensitive optical immunoassay platform, which comprises two pivotal components: one dedicated to establishing highly sensitive sandwich immunocomplexes for ...